Protocol summary

Study aim
The aim of this study was to treat constipation in burn patients. Which in the guidelines this process takes place after three to five days, but in this study, one day is considered.
Design
This study was a parallel randomized controlled trial study design. The sample size of the study is 120 patients that will be assigned to intervention and control groups using simple randomization method.
Settings and conduct
Evaluate and prescribe daily interventions versus three and five days recommended in the guideline, to prevent wound infection caused by constipation. This study will be performed in Motahhari Burn Hospital of Iran University of Medical Sciences. Confirmed patients and hospitalization in burn and intensive care units will be followed for 3 days after receiving Intended interventions, in terms of outcomes. Because the intervention processes in the groups are completely different, the outcome assessor will be blinding of the type of interventions received by the participants.
Participants/Inclusion and exclusion criteria
Patients with grade III and IIb burns, with a burn percentage of 20 to 30, will be selected for the study. In addition, any selected patients with a history of neurological, psychological, diabetes, hypertension, trauma other than burns, and inflammatory bowel disease will be excluded.
Intervention groups
Patients in the intervention group are prescribed oral adult Bisacodyl tablet (40 mg), adult Bisacodyl suppository, c-lax tablet, and lactulose during the outcome assessment. Patients in the control group are also given oral Bisacodyl and Bisacodyl suppositories during the outcome evaluation if the patient does not respond, finally, the patient is given normal saline enema on the third day.
Main outcome variables
Evaluation of constipation status, wound infection, incidence of burn wound infection, incidence of constipation

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20201226049834N1
Registration date: 2021-05-01, 1400/02/11
Registration timing: prospective

Last update: 2021-05-01, 1400/02/11
Update count: 0
Registration date
2021-05-01, 1400/02/11
Registrant information
Name
Aliakbar Jafarian
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 6653 9260
Email address
jafarian.ak@iums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-05-05, 1400/02/15
Expected recruitment end date
2021-12-22, 1400/10/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of treatment of constipation-induced infection in patients with grade IIb, III skin burn
Public title
Evaluation of treatment of constipation induced infection
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Grade IIb, III upper-lower limb burns Burn percentage between 20 to 30
Exclusion criteria:
History of neurological diseases including dementia, Alzheimer's, Parkinson's History of psychologic illnesses including known and treated depression and anxiety, mania and schizophrenia Any allergies to laxatives or enzymes used History of Inflammatory bowel disease and Irritable bowel syndrome Coma or loss of consciousness Moderate to severe water and electrolyte disturbance Simultaneous presence of other traumas other than burns Perineal or anal burns History of diabetes, hypertension, heart, respiratory, liver and kidney
Age
From 20 years old to 40 years old
Gender
Both
Phase
3
Groups that have been masked
  • Outcome assessor
Sample size
Target sample size: 120
Randomization (investigator's opinion)
Randomized
Randomization description
After the participants were selected to study, we will use simple randomization method to assign to the groups for received intervention and placebo. The randomization process will be performed using Random Allocation software, and since this study consists of two groups, the allocation outputs of the participants will be identified by A and B so the assign of each patient in each group is unpredictable to other members of the research team. We will notify for the team manager after selecting each patient and they will send out each patient's intervention type based on the software output. In this process will be informed of the type of intervention of each patient only clinical caregiver in unfavorable clinical conditions of patients.
Blinding (investigator's opinion)
Single blinded
Blinding description
Single blinding was considered for this study. Due to the different process of interventions in the study groups, only the patient outcome assessor will be blinded of the type of patient interventions.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Approval date
2020-11-11, 1399/08/21
Ethics committee reference number
IR.IUMS.REC.1399.797

Health conditions studied

1

Description of health condition studied
Constipation
ICD-10 code
K59.0
ICD-10 code description
Constipation

Primary outcomes

1

Description
Evaluation of patients' constipation status
Timepoint
Maximum three days and examination every 12 hours from the beginning of the interventions
Method of measurement
Examination and clinical questions

2

Description
Wound infection caused by constipation
Timepoint
Duration of hospitalization of patients in infectious wards and intensive care
Method of measurement
Clinical examination and laboratory results

Secondary outcomes

1

Description
incidence of burn wound infection
Timepoint
Duration of hospitalization of patients in infectious wards and intensive care
Method of measurement
Clinical examination and laboratory results

2

Description
incidence of constipation
Timepoint
Duration of hospitalization of patients in infectious wards and intensive care
Method of measurement
Patient records and clinical examinations

Intervention groups

1

Description
Intervention group: Patients in this group will be treated for symptomatic constipation according to the guideline. The procedure is as follows: One adult Bisacodyl tablet (40 mg) is given. If no defecated within six hours, take two more oral tablets, and if not observed within six hours, use an adult Bisacodyl suppository, and if no response after six hours, take two oral c-lax tablets in the same way as when taking Bisacodyl was prescribed and in case of no response to lactulose in the amount of 20 cc and in case of no response in the amount of 50 cc to the patient.
Category
Treatment - Drugs

2

Description
Control group: If the patient does not defecate for more than five days or the patient feels pain and discomfort from not defecating, the patient is first given two Bisacodyl oral tablets. If the previous treatment does not respond, the adult Bisacodyl suppository is given in two stages at 24-hour intervals, and finally the patient is given normal saline enema on the third day.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Mottahari Burns Hospital
Full name of responsible person
Aliakbar Jafarian
Street address
Mottahari Burns Hospital, Valiasr St
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8877 0031
Email
Jafarian.ak@iums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Abbas Motavalian
Street address
Iran University of Medical Sciences, Shahid Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8670 2503
Email
research-m@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Aliakbar Jafarian
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Mottahari Burns Hospital, Valiasr St
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8877 0031
Email
Jafarian.ak@iums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Aliakbar Jafarian
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Mottahari Burns Hospital, Valiasr St
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8877 0031
Email
Jafarian.ak@iums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Aliakbar Jafarian
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Mottahari Burns Hospital, Valiasr St
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8877 0031
Email
Jafarian.ak@iums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...